Cronos Group Inc. (NASDAQ:CRON - Get Free Report) fell 3.3% during mid-day trading on Friday . The stock traded as low as $2.66 and last traded at $2.66. 743,260 shares changed hands during mid-day trading, a decline of 73% from the average session volume of 2,785,273 shares. The stock had previously closed at $2.75.
Analysts Set New Price Targets
Separately, Bank of America boosted their price target on shares of Cronos Group from $1.78 to $2.00 and gave the company an "underperform" rating in a research report on Thursday, December 28th.
Read Our Latest Research Report on Cronos Group
Cronos Group Trading Down 2.5 %
The stock's fifty day moving average is $2.25 and its two-hundred day moving average is $2.07. The firm has a market cap of $1.02 billion, a P/E ratio of -14.11 and a beta of 1.17.
Cronos Group (NASDAQ:CRON - Get Free Report) last posted its earnings results on Thursday, February 29th. The company reported ($0.05) earnings per share for the quarter. The firm had revenue of $23.92 million for the quarter, compared to the consensus estimate of $25.15 million. Cronos Group had a negative return on equity of 3.99% and a negative net margin of 84.15%. On average, analysts forecast that Cronos Group Inc. will post -0.01 EPS for the current year.
Institutional Trading of Cronos Group
Hedge funds and other institutional investors have recently bought and sold shares of the company. Intact Investment Management Inc. increased its holdings in shares of Cronos Group by 54.2% in the 3rd quarter. Intact Investment Management Inc. now owns 1,108,300 shares of the company's stock worth $2,211,000 after buying an additional 389,610 shares during the last quarter. JW Asset Management LLC bought a new position in shares of Cronos Group in the 3rd quarter worth $400,000. AdvisorShares Investments LLC bought a new position in shares of Cronos Group in the 3rd quarter worth $280,000. Vontobel Holding Ltd. increased its holdings in shares of Cronos Group by 139.1% in the 3rd quarter. Vontobel Holding Ltd. now owns 214,560 shares of the company's stock worth $428,000 after buying an additional 124,820 shares during the last quarter. Finally, Revisor Wealth Management LLC bought a new position in shares of Cronos Group in the 3rd quarter worth $47,000. Institutional investors own 8.71% of the company's stock.
Cronos Group Company Profile
(
Get Free Report)
Cronos Group Inc operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones brand in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets.
Featured Articles
Before you consider Cronos Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cronos Group wasn't on the list.
While Cronos Group currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.
Get This Free Report
